OCA
GOSS icon

Octagon Capital Advisors’s Gossamer Bio GOSS Stock Holding History

Octagon Capital Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.28M Hold
7,750,000
– – 0.11% 27
2026
Q1 		$2.55M Sell
7,750,000
-6,165,371
-44% -$9.69M 0.28% 29
2025
Q4 		$43.1M Sell
13,915,371
-3,134,629
-18% -$8.94M 5.24% 5
2025
Q3 		$44.8M Sell
17,050,000
-1,300,000
-7% -$2.87M 6.8% 3
2025
Q2 		$22.6M Hold
18,350,000
– – 4.95% 6
2025
Q1 		$20.2M Hold
18,350,000
– – 3.91% 7
2024
Q4 		$16.6M Buy
18,350,000
+9,162,117
+100% +$7.85M 2.73% 15
2024
Q3 		$9.06M Hold
9,187,883
– – 1.41% 20
2024
Q2 		$8.28M Hold
9,187,883
– – 1.3% 20
2024
Q1 		$10.8M Hold
9,187,883
– – 1.3% 24
2023
Q4 		$8.38M Buy
9,187,883
+1,000,000
+12% +$739K 1.34% 19
2023
Q3 		$6.82M Buy
8,187,883
+4,229,814
+107% +$4.87M 1.05% 20
2023
Q2 		$4.75M Buy
3,958,069
+2,000,000
+102% +$2.49M 0.66% 28
2023
Q1 		$2.47M Hold
1,958,069
– – 0.36% 30
2022
Q4 		$4.25M Sell
1,958,069
-87,373
-4% -$719K 0.66% 24
2022
Q3 		$24.5M Sell
2,045,442
-712,627
-26% -$8.85M 4.23% 5
2022
Q2 		$23.1M Buy
2,758,069
+194,931
+8% +$1.51M 6.16% 5
2022
Q1 		$22.2M Buy
2,563,138
+1,050,000
+69% +$10.1M 4.81% 6
2021
Q4 		$17.1M Hold
1,513,138
– – 3.33% 11
2021
Q3 		$19M Buy
1,513,138
+100,000
+7% +$921K 4.68% 7
2021
Q2 		$11.5M Hold
1,413,138
– – 2.38% 14
2021
Q1 		$13.1M Sell
1,413,138
-150,000
-10% -$1.51M 4.92% 6
2020
Q4 		$15.1M Buy
+1,563,138
New +$15.4M 5.24% 8

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Octagon Capital Advisors's GOSS Position: Q2 2026 in Review

Octagon Capital Advisors held its Gossamer Bio (GOSS) position steady in Q2 2026 at 7,750,000 shares worth $1.28M. The position accounts for 0.11% of the portfolio, ranked #27.

Octagon Capital Advisors first reported a position in GOSS in Q4 2020 and has held it in 23 quarters since. The position peaked at $44.8M in Q3 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Octagon Capital Advisors held 7,750,000 shares of Gossamer Bio worth $1.28M as of Q2 2026.
  • Octagon Capital Advisors left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up 0.11% of Octagon Capital Advisors's portfolio in Q2 2026, its #27 holding.
  • Octagon Capital Advisors first reported a position in Gossamer Bio in Q4 2020 and has held it in 23 quarters since.
  • Octagon Capital Advisors's Gossamer Bio position peaked at $44.8M in Q3 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Octagon Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.